Compare PCT & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PCT | SGHT |
|---|---|---|
| Founded | 2015 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Environmental Services | Medical Specialities |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 556.5M | 489.7M |
| IPO Year | 2020 | 2021 |
| Metric | PCT | SGHT |
|---|---|---|
| Price | $1.72 | $10.80 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 8 |
| Target Price | $6.40 | ★ $12.25 |
| AVG Volume (30 Days) | ★ 8.6M | 374.7K |
| Earning Date | 11-04-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 30.86 | 28.16 |
| EPS | N/A | ★ N/A |
| Revenue | $8,355,000.00 | ★ $77,363,000.00 |
| Revenue This Year | $269.48 | $19.69 |
| Revenue Next Year | $262.99 | $12.19 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.60 | $3.38 |
| 52 Week High | $14.20 | $11.60 |
| Indicator | PCT | SGHT |
|---|---|---|
| Relative Strength Index (RSI) | 26.91 | 69.36 |
| Support Level | $1.60 | $7.88 |
| Resistance Level | $3.53 | N/A |
| Average True Range (ATR) | 0.35 | 0.63 |
| MACD | -0.03 | 0.14 |
| Stochastic Oscillator | 6.20 | 70.72 |
PureCycle Technologies Inc is a Florida-based corporation focused on commercializing a patented dissolution process to physically separate the polymer from other plastics, color, and contaminants (the Technology), originally developed by The Procter & Gamble Company (P&G), for restoring waste polypropylene into resin with near-virgin characteristics, called PureFive resin. PureFive resin represents the family of recycled resin products produced, including ultra-pure resin and other grades used for compounding to meet customer specifications, which has similar properties and applicability for reuse as virgin polypropylene. It has a single operating segment, which encompasses integrated business activities related to the recycling of polypropylene into resins.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.